Understanding Ankylosing Spondylitis

Ankylosing spondylitis (AS) is a chronic inflammatory arthropathy that primarily affects the spine and sacroiliac joints. It typically emerges in people aged 20–40 and progresses insidiously, causing progressive fusion of spinal segments if left untreated.

  • Spinal involvement: Pain and stiffness begin in the lower back and gradually ascend the spine.
  • Systemic features: Fatigue, low-grade fever, and unexplained weight loss often accompany joint symptoms.
  • Extra-articular manifestations: Anterior uveitis (eye inflammation) occurs in up to 40% of patients.
  • Genetic link: The HLA-B27 gene is present in 90% of AS patients, though genetic predisposition alone does not cause disease.

Early diagnosis and aggressive anti-inflammatory therapy can halt or slow progression, making periodic disease activity assessment essential.

BASDAI Calculation Method

The BASDAI score synthesises responses to six questions, each scored 0–10. The formula weights morning stiffness separately because questions 5 and 6 both address this symptom.

BASDAI = [(Q1 + Q2 + Q3 + Q4 + (Q5 + Q6) ÷ 2) ÷ 5]

  • Q1 — Fatigue or tiredness severity
  • Q2 — Ankylosing spondylitis neck, back, or hip pain
  • Q3 — Pain or swelling in joints other than neck, back, or hips
  • Q4 — Discomfort from areas that are tender to touch or pressure
  • Q5 — Morning stiffness severity when waking
  • Q6 — Duration of morning stiffness in minutes

The Six BASDAI Questions

Each question requires a response on a numerical rating scale from 0 (no symptoms) to 10 (severe symptoms). Patients should answer based on the preceding week.

  1. Fatigue: Rate the severity of tiredness and exhaustion.
  2. Spinal pain: Assess pain in the neck, back, or hip region attributable to AS.
  3. Peripheral joint pain: Evaluate pain or swelling in other joints (knees, shoulders, ankles, etc.).
  4. Localized tenderness: Score discomfort when pressure is applied to areas of inflammation or sensitivity.
  5. Morning stiffness severity: Rate how stiff your spine and joints feel upon waking.
  6. Morning stiffness duration: Record how many minutes stiffness persists after waking.

The calculator averages questions 5 and 6 to create a single stiffness metric, then divides the total by 5 to produce a final score between 0 and 10.

Interpreting Your BASDAI Score

BASDAI scores provide clinicians and patients with a quantitative snapshot of disease activity:

  • 0–2: Minimal disease activity; current therapy is likely effective.
  • 2–4: Low-to-moderate disease activity; most patients remain stable.
  • 4–6: Moderate disease activity; treatment adjustment may be warranted.
  • 6–10: High disease activity; escalation of therapy or investigation of adherence issues is recommended.

A change of 1.5 points or greater is considered clinically meaningful and may trigger a change in management strategy. Regular monitoring helps identify flares early and optimises long-term outcomes.

Clinical Pearls and Limitations

Several factors can influence BASDAI accuracy and interpretation.

  1. Morning stiffness duration must be measured accurately — Patients often overestimate or underestimate stiffness duration. Use a timer and record the actual time until symptoms improve, not when they fully resolve. This question carries significant weight in the final calculation.
  2. Scores may not capture structural damage — BASDAI measures disease activity (symptoms and inflammation) but not spinal fusion or permanent damage. Patients with long-standing AS and advanced structural changes may have falsely low scores despite significant functional limitation.
  3. Medication timing affects responses — Ask patients to complete the assessment at a consistent time of day—ideally before their first dose of anti-inflammatory medication. Morning administration of NSAIDs or biologics can artificially lower scores if timed inappropriately.
  4. Consider comorbidities and mental health — Fatigue and pain are non-specific; depression, sleep apnoea, and other chronic illnesses can inflate BASDAI scores independent of AS activity. Clinicians should investigate contextual factors when scores seem disproportionate to imaging findings.

Frequently Asked Questions

What is the difference between BASDAI and other AS activity measures?

BASDAI is a patient-reported outcome measure focusing on symptom severity, whereas imaging-based measures (ASDAS-CRP, ASDAS-ESR) incorporate C-reactive protein or erythrocyte sedimentation rate alongside patient responses. ASDAS is more sensitive to acute inflammation but requires blood tests, making it less suitable for frequent home monitoring. BASDAI remains the gold standard for bedside assessment and clinical trials due to its simplicity and responsiveness.

Can I use BASDAI to diagnose ankylosing spondylitis?

No. BASDAI is a disease activity index for patients with established AS diagnosis. It does not diagnose the condition. Diagnosis requires clinical symptoms, imaging evidence (sacroiliitis on MRI or X-ray), and usually positive HLA-B27 serology. A rheumatologist must evaluate clinical presentation, laboratory findings, and structural changes before applying BASDAI.

How often should I calculate my BASDAI score?

Frequency depends on clinical context. Patients on stable therapy may assess BASDAI monthly or quarterly. Those starting or changing medication should score weekly for 4–6 weeks to detect response. During acute flares, more frequent assessment (every few days) helps determine whether intervention is working. Discuss frequency with your rheumatologist, as overmonitoring can create unnecessary anxiety.

Does BASDAI improve with TNF-inhibitor therapy?

Yes. TNF inhibitors (biologics) typically reduce BASDAI scores by 40–60% within 12 weeks in responsive patients. Responders often achieve clinically meaningful reductions (≥1.5 points) and may reach remission (BASDAI <4). However, approximately 30% of patients show suboptimal response and require switching to an alternative biologic or conventional DMARD therapy.

Why do questions 5 and 6 get averaged in the formula?

Questions 5 and 6 both assess morning stiffness—one measures severity and the other measures duration. Averaging them prevents double-weighting of a single symptom domain. This approach distributes disease activity assessment equally across five symptom categories: fatigue, spinal pain, peripheral joint pain, localized tenderness, and morning stiffness.

Can BASDAI scores fluctuate unpredictably?

Minor day-to-day variation is normal and often reflects natural symptom fluctuation. However, large swings (≥2 points within a week) may indicate medication non-adherence, environmental triggers (infection, stress, overexertion), or disease flare. Consistent monitoring helps distinguish noise from genuine worsening and prevents overtreatment based on single outlier measurements.

More health calculators (see all)